FdaApplication

ANDA 207684

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCIPLA LTD
application_typeANDA
approval_date2017-08-03

Products (1)

ProductActive ingredientStrengthDosage form
NEVIRAPINENEVIRAPINE50MG/5MLSUSPENSION;ORAL

1 product